Embecta Corp. Common Stock (EMBC) is a publicly traded Healthcare sector company. As of May 21, 2026, EMBC trades at $3.06 with a market cap of $179.76M and a P/E ratio of 1.84. EMBC moved +5.34% today. Year to date, EMBC is -73.67%; over the trailing twelve months it is -75.10%. Its 52-week range spans $2.77 to $21.48. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces EMBC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
EMBC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EMBC recently traded at $3.06. Market cap is $179.76M. P/E ratio is 1.84. Revenue is $1.08B.
| Metric | Value |
|---|---|
| Price | $3.06 |
| Market Cap | $179.76M |
| P/E Ratio | 1.84 |
| EPS | $1.64 |
| Dividend Yield | 0.01% |
| 52-Week High | $21.48 |
| 52-Week Low | $2.77 |
| Volume | 1.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.08B |
| Net Income | $95.40M |
| Gross Margin | 62.64% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.08B | $95.40M | $1.64 |
| 2024 | $1.12B | $78.30M | $1.36 |
| 2023 | $1.12B | $70.40M | $1.23 |
| 2022 | $1.13B | $223.60M | $3.92 |
2 analysts cover EMBC: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.